Phathom Pharmaceuticals (PHAT) executive compensation, 2026 proxy

Steven Basta, President and Chief Executive Officer, was paid $7M in 2025.

Filed
April 7, 2026
Annual meeting
May 19, 2026
Pay year
2025
Named executives
5
CEO total pay
$7M2025
CEO pay in equity
86%$6M in awards
Prior say-on-pay support
98%of votes cast
Say-on-pay support
98%Votes cast in favor
CEO 2025 Salary
$525,000Joined April 1, 2025

How Basta was paid

$7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary8%Stock awards29%Option awards57%Non-equity incentive7%All other compensation0%

Named executive officers

ExecutiveTotal
Steven BastaPresident and Chief Executive Officer$6,968,070
Sanjeev NarulaChief Financial and Business Officer$3,617,962
Anne Marie CookChief Legal Officer and Secretary$2,100,002
Terrie CurranFormer President and Chief Executive Officer$4,936,791
Azmi Nabulsi, M.D., M.P.H.Former Chief Operating Officer$2,714,314

What changed and why

  • $7MSteven Basta served as President and Chief Executive Officer with a total compensation of $6,968,070 for 2025.
  • 98%Shareholders showed strong support with approximately 98% of votes cast in favor of the say-on-pay proposal in June 2025.
  • The compensation committee maintained the general structure of the executive compensation program following the strong advisory vote support.
  • Pay Governance LLC served as the independent compensation consultant to assist with peer group comparisons and market analyses.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.